Growth Metrics

Burning Rock Biotech (BNR) Consolidated Net Income: 2019-2025

Historic Consolidated Net Income for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $16.8 million.

  • Burning Rock Biotech's Consolidated Net Income fell 91.19% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 106.92%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Consolidated Net Income of $16.8 million as of Q3 2025, which was up 182.30% from -$20.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Consolidated Net Income high stood at $614.6 million for Q4 2022, and its period low was -$231.4 million during Q3 2022.
  • Moreover, its 3-year median value for Consolidated Net Income was -$20.5 million (2025), whereas its average is $327,909.
  • The largest annual percentage gain for Burning Rock Biotech's Consolidated Net Income in the last 5 years was 1,609.78% (2022), contrasted with its biggest fall of 775.17% (2022).
  • Over the past 5 years, Burning Rock Biotech's Consolidated Net Income (Quarterly) stood at -$40.7 million in 2021, then surged by 1,609.78% to $614.6 million in 2022, then plummeted by 35.33% to $397.4 million in 2023, then crashed by 102.07% to -$8.2 million in 2024, then plummeted by 91.19% to $16.8 million in 2025.
  • Its Consolidated Net Income stands at $16.8 million for Q3 2025, versus -$20.5 million for Q2 2025 and -$13.1 million for Q1 2025.